In Reply.

Obstet Gynecol

Division of Pharmacovigilance II, Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology and Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

Published: October 2017

Download full-text PDF	Source
http://dx.doi.org/10.1097/AOG.0000000000002291	DOI Listing

Publication Analysis

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!